AISAP Cardio vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AISAP
VS
by iRhythm Technologies, Inc.

AI Verdict

AISAP Cardio is designed for rapid, point-of-care ultrasound assessments of structural heart disease and heart failure, providing immediate diagnostic insights. In contrast, the Zio AT ECG Monitoring System offers continuous, long-term wearable ECG monitoring specifically for detecting arrhythmias. While both leverage AI in cardiology, they serve distinct diagnostic needs—one for structural assessment via ultrasound, the other for electrical activity monitoring via ECG.

Choose AISAP Cardio if…

Choose AISAP Cardio if you require rapid, AI-powered point-of-care ultrasound diagnostics for immediate assessment of structural heart disease or heart failure at the patient's bedside. This tool is ideal for quickly obtaining comprehensive cardiac measurements and interpretations to guide urgent clinical decisions.

View AISAP Cardio →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT ECG Monitoring System if you need continuous, long-term ECG monitoring to detect intermittent or asymptomatic arrhythmias over an extended period, up to 14 days. This wearable solution is best suited for remote patient monitoring and capturing elusive cardiac events that may not be present during a brief in-office examination.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AISAP Cardio Zio AT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment Cloud-based Cloud-based (data analytics and clinician portal)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio AT ECG Monitoring System

While AISAP Cardio streamlines POCUS for clinicians, Zio AT offers a comprehensive and highly patient-centric usability experience with its comfortable wearable patch, patient mobile app for symptom logging, and a clinician portal for easy management and report interpretation. The high patient compliance and preference over traditional Holter monitors highlight its superior usability for both patients and providers in its specific use case.

Clinical Value

Tie

Both tools demonstrate significant and validated clinical value in their respective domains. AISAP Cardio excels in rapid, accurate point-of-care diagnosis of structural heart disease and heart failure, empowering a broader range of clinicians. Zio AT provides superior long-term, continuous arrhythmia detection compared to traditional methods, leading to higher diagnostic yields and changes in patient management. Their distinct clinical applications are both highly impactful.

Pricing & Value

Zio AT ECG Monitoring System

While both tools lack public pricing, Zio AT provides more transparency around its service fee model, insurance coverage, and patient financial assistance programs, which adds tangible value and accessibility for patients and providers. The clear CPT codes and reimbursement information, despite past fluctuations, offer a more defined financial pathway.

Enterprise Readiness

Zio AT ECG Monitoring System

Tool B explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for enterprise adoption in healthcare. While Tool A emphasizes integration and scalability, the explicit compliance statements from Tool B provide greater assurance for large-scale deployment and data handling.

Innovation

Tie

Both tools are highly innovative, applying AI to different critical aspects of cardiac care. AISAP Cardio pioneers AI-powered POCUS for comprehensive structural heart disease diagnosis at the bedside, enabling non-cardiologists. Zio AT innovates with its long-term wearable, continuous monitoring, and deep-learned AI for superior arrhythmia detection, transforming remote cardiac diagnostics. Both represent significant advancements in their respective fields.

Support & Docs

Zio AT ECG Monitoring System

Tool B offers more explicit and comprehensive support channels, including 24/7 phone and email support for both patients and providers, along with dedicated resources for billing and patient education. While Tool A provides contact information and a member portal, Tool B's round-the-clock availability and broader resource offerings indicate a more robust support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AISAP Cardio Zio AT ECG Monitoring System
Name AISAP Cardio Zio AT ECG Monitoring System
Company Aisap iRhythm Technologies, Inc.
Primary Function/Category AI-powered point-of-care ultrasound (POCUS) software for cardiac diagnostic assessments Wearable mobile cardiac telemetry (MCT) service for continuous, AI-powered ECG monitoring
Specialties Cardiology, Emergency Medicine, Radiology Cardiology
Key AI-powered Capability AI-powered interpretation for early cardiac disease detection, automated generation of analyses, interpretations, and reports FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection
Specific Measurements/Monitoring Assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), Measurement of Left Ventricle Ejection Fraction (LVEF), right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter Continuous, uninterrupted ECG recording for up to 14 days, detection of symptomatic and asymptomatic cardiac events

Videos

Demos, reviews, and walkthroughs featuring AISAP Cardio and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AISAP Cardio focuses on rapid, comprehensive cardiac diagnostic assessments and measurements for early detection of structural heart disease and heart failure at the bedside. The Zio AT ECG Monitoring System provides continuous, AI-powered ECG monitoring for long-term arrhythmia detection.
AISAP Cardio utilizes AI-powered point-of-care ultrasound software for interpreting cardiac images and generating diagnostic reports. In contrast, the Zio AT system employs a wearable patch for continuous ECG recording and a deep-learned AI algorithm for arrhythmia detection.
AISAP Cardio assesses valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), Left Ventricle Ejection Fraction (LVEF), and various ventricular/atrial dimensions, along with ascending aorta and IVC diameters. The Zio AT system is designed to detect symptomatic and asymptomatic cardiac events through continuous ECG monitoring for up to 14 days.
AISAP Cardio is a cloud-based SaaS platform designed for integration with EHR/EMR and PACS, generating automated analyses and reports at the point of care. The Zio AT system uses a wearable patch with real-time data transmission to a cloud-based clinician portal, providing comprehensive end-of-wear reports.
The Zio AT ECG Monitoring System explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA). AISAP Cardio also uses a secure, HIPAA-compliant and ISO-certified cloud for data transmission.
AISAP Cardio is designed for Cardiology, Emergency Medicine, and Radiology specialties. The Zio AT ECG Monitoring System primarily targets Cardiology.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.